DermaKnowlogy ApS: Financial statements 2023
CVR: 10055318
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
DermaKnowlogy ApS (CVR 10055318) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -736,772 and a net result of DKK -908,301 compared with DKK -955,201 the year before. Equity in the 2023 report amounted to DKK -5,426,480. The company had 1 employee in the financial year.
- Gross Profit
- DKK -736,772
- Profit/Loss
- DKK -908,301
- Equity
- DKK -5,426,480
- Total Assets
- DKK 856,341
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -737 t. | -908 t. | -5.4 mio. | 1 |
| 2022 | - | -920 t. | -955 t. | -4.5 mio. | - |
| 2021 | - | -654 t. | -714 t. | -3.6 mio. | - |
| 2020 | - | -559 t. | -641 t. | -2.8 mio. | - |
| 2019 | - | -1.7 mio. | -1.5 mio. | -2.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 18, 2023, DERMA PHARM A/S is registered as an owner of DermaKnowlogy ApS with an ownership share of 66%.
As of November 18, 2023, Uffe Koppelhus Holding ApS is registered as an owner of DermaKnowlogy ApS with an ownership share of 25%.
As of September 20, 2023, A/S PSE 17 NR. 1056 has been appointed auditor of DermaKnowlogy ApS.
As of September 20, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of DermaKnowlogy ApS.
DermaKnowlogy ApS has published its annual report for 2022. Gross profit came to DKK -920,155, and the net result was DKK -955,201.
About DermaKnowlogy ApS
DermaKnowlogy ApS is a Danish company of the type Anpartsselskab based in Fårup, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named SCAN CARE ApS and PBH 27.488 ApS. The management consists of Peter Bogh. The board consists of Mikkel Egelund Jensen (chair), Peter Bogh and Uffe Koppelhus. The company is owned by DERMA PHARM A/S and Uffe Koppelhus Holding ApS. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -618,011 and a net result of DKK -607,032 compared with DKK -882,036 the year before. Equity in the 2025 report amounted to DKK -6,915,548.